Daniel K Rieger

Title: The Innovative Contributions of Daniel K Rieger

Introduction

Daniel K Rieger is a notable inventor based in Branford, CT (US), recognized for his significant contributions to the field of biotechnology. He holds a total of four patents, showcasing his expertise and innovative spirit in developing novel polypeptides and nucleic acids.

Latest Patents

Among his latest patents is the invention of FGF-CX, a novel isolated polypeptide. This invention includes a polynucleotide encoding FGF-CX and antibodies that specifically bind to FGF-CX or any of its derivatives, variants, mutants, or fragments. The applications of this invention extend to methods for detection and treatment of various pathological states. Another significant patent involves nucleic acid sequences that encode novel polypeptides, along with the corresponding polypeptides and antibodies. This invention also outlines therapeutic, diagnostic, and research methods for the diagnosis, treatment, and prevention of disorders related to these novel human nucleic acids and proteins.

Career Highlights

Daniel K Rieger has worked with Curagen Corporation, where he further honed his skills and contributed to groundbreaking research in biotechnology. His work has had a lasting impact on the field, particularly in the development of therapeutic solutions.

Collaborations

Throughout his career, Rieger has collaborated with notable individuals such as Ferenc L Boldog and Catherine Burgess. These collaborations have enriched his research and contributed to the advancement of his inventions.

Conclusion

Daniel K Rieger's innovative work in biotechnology, particularly in the development of polypeptides and nucleic acids, has made a significant impact in the field. His patents reflect a commitment to advancing medical science and improving therapeutic methods.